The angiotensin converting enzyme genetic polymorphism in acute coronary syndrome - ACE polymorphism as a risk factor of acute coronary syndrome

Journal of Korean Medical Science

Volumn 12, Issue 5, 1997, Pages 391-397

  Park, Hyun Young ^a   Kwon, Hyuck Moon ^a   Kim, Dongsoo ^a,b   Jang, Yangsoo ^a   Shim, Won Heum ^a   Cho, Seung Yeon ^a   Kim, Hyun Seung ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Angiotensin converting enzyme; Coronary disease; Peptidyl dipeptidase A; Polymorphism (Genetics)

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE DISEASE; ARTERY; ARTICLE; CORONARY BLOOD VESSEL; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEART INFARCTION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ANGINA, UNSTABLE; ARTERIES; CORONARY VESSELS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0031241802     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1997.12.5.391     Document Type: Article

References (29)

1. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990 ; 16 : 363-70.
2. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Richard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992 ; 359 : 641-4.
3. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993 ; 44 : 292-7.
4. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995 ; 332 : 706-11.
5. Marrop SB, Davidson HR, Connor JM. The angiotensin I-converting enzyme gene and predisposition to high blood pressure. Hypertension 1993 ; 21 : 455-60.
6. Shunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil H, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Eng J Med 1994 ; 330 : 1634-8.
7. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Ferryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993 ; 342 : 1073-5.
8. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ. Lack of association between the Insertion/Deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995 ; 25 : 1627-31.
9. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995 ; 91 : 2120-4.
10. Markus HS, Barley J, Lunt R, Bland J, Jeffery S, Carter ND, Brown MM. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995 ; 26 : 1329-33.
11. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993 ; 91 : 1453-8.
12. Chobanian AV, Haudenschild CC, Niekerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990 ; 15 : 327-31.
13. Falk E, Shah PK, Fuster V. Coronary plaque disruption Circulation 1995 ; 92 : 657-71.
14. Lee MM, Kim HS, Song JM, Choi YJ, Kim DK, Sohn DW, Oh BH, Park YB, Choi YS, Seo JD, Lee YW. Insertion/ Deletion polymorphism of angiotensin I-converting enzyme gene in Korean patients with ischemic heart disease. The Korean Circulation Journal 1996 ; 26 : 5-13.
15. Park HY, Kwon HM, Kim HS, Song KS, Kim CH. An I/D polymorphism in angiotensin-converting enzyme gene in myocardial infarction. The Korean Circulation Journal 1996 ; 26 : 465-72.
16. Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Verho M, Gross W, Marz W. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with Increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996; 125 : 19-25.
17. Brown BG, Bolson EL, Dodge HT. Dynamic mechanisms in human coronary stenosis. Circulation 1984 ; 70 : 917-22.
18. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989 ; 79 : 101-6.
19. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987 ; 316 : 1514-8.
20. Jan Danser AH, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/ insertion polymorphism. Circulation 1995 ; 92 : 1387-8.
21. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvel P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme level. J Clin Invest 1990 ; 86 : 1343-6.
22. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmans H, Waas W, Haberbosch W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme gene is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995 ; 92 : 2796-9.
23. Lachurie ML, Azizi M, Guyene TT, Alhenc-Gelas F, Menard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995 ; 91 : 2933-42.
24. Diet F, Pratt RE, Berry GJ, Momose N, Gibbon GH, Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996 ; 94 : 2756-67.
25. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 1993 ; 87 : 1969-73.
26. Van Leeuwen RTJ, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator mRNA in cultured rat aortic smooth muscle cells. Circulation 1994 ; 90 : 362-8.
27. 2+ concentrations in essential hypertension Hypertension 1993 ; 22 : 853-62.
28. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Combien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992 ; 51 : 197-205.
29. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population Biochem Biophys Res Commun 1993 ; 191 : 399-404.